KZR KEZAR LIFE SCIENCES INC Dividend Policy Changes 8-K Filing 2024 - Rights Plan Adopted Kezar Life Sciences declared a dividend of rights to purchase preferred stock and adopted a rights plan to protect against a potential takeover by Concentra Biosciences, which proposed to acquire the company for $1.10 per share; the company has approximately $148 million in cash and marketable securities as of September 30, 2024.Get access to all SEC 8-K filings of the KEZAR LIFE SCIENCES INC